A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.
about
Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virusRegulation and cellular roles of ubiquitin-specific deubiquitinating enzymesBroad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family CoronaviridaeFrom SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug designSevere Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological EvaluationPapain-Like Protease 1 from Transmissible Gastroenteritis Virus: Crystal Structure and Enzymatic Activity toward Viral and Cellular SubstratesDiscovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV)X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like ProteasesStructural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like proteaseSmall molecule deubiquitinase inhibitors promote macrophage anti-infective capacityProtein Interferon-Stimulated Gene 15 Conjugation Delays but Does Not Overcome Coronavirus Proliferation in a Model of Fulminant HepatitisStructural view and substrate specificity of papain-like protease from avian infectious bronchitis virus.A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantThe SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease.Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.Deubiquitinating enzymes as promising drug targets for infectious diseases.Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization.Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signalingA chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronavirusesHepatitis E virus inhibits type I interferon induction by ORF1 productsCoronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistanceProteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome.Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis.Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications.Development of inhibitors in the ubiquitination cascade.Sculpting the proteome with small moleculesPharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.A small molecule deubiquitinase inhibitor increases localization of inducible nitric oxide synthase to the macrophage phagosome and enhances bacterial killingSARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzymeComparison of SARS and NL63 papain-like protease binding sites and binding site dynamics: inhibitor design implicationsX-ray Structural and Functional Studies of the Three Tandemly Linked Domains of Non-structural Protein 3 (nsp3) from Murine Hepatitis Virus Reveal Conserved Functions.Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoVAssessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.DUBs at a glance.Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitorsInterferon-Stimulated Gene 15 in the Control of Cellular Responses to Genotoxic Stress.
P2860
Q21131361-A4035FF1-D123-4AFC-8B00-3B3FC5BB3A57Q24645701-F0A6D596-05A6-43C5-93CC-9DB8E5229CF2Q24648487-1967F3F9-F989-4AEE-9EB2-F5E850C2BC99Q26992345-5B480A52-24BD-41FE-856E-22218526FAABQ27662127-A465095C-4521-4D3A-9CB4-FA5B18CBB648Q27663641-047760AC-D310-4C5F-9FA8-4670CA9032CFQ27675449-E2E8AE63-8081-49AE-AC33-1A507820E950Q27681891-6D898760-6644-4F74-93DE-902E7E214035Q27689096-F09BDAFB-A67A-47A1-9B9F-3ECC3FF59038Q28541638-56AC323D-3073-4BF1-B983-589596E10E41Q30049307-09CA9246-4B3D-4479-A6BA-7D401B190741Q30153246-5AAFC5B4-83A4-4E94-BFE6-DB59846F36A6Q30360627-F70257E2-E9B6-4439-8E3B-AC5979E42C11Q30370367-E6D5E7DA-D328-4ACD-8151-5D53A68ADCB5Q33488957-1C9A47F9-F932-4819-8855-62C7ABAEAF1FQ33826676-48327F4B-A843-4388-88B4-EFE9ADCD463EQ33836097-380DB4EE-89D4-46B8-B802-C9B3B4554BC1Q33979228-C2FC4B32-9DE7-48CE-ADF8-2C7B6B8A2156Q34058365-3090486F-6F23-4EC8-A39A-A8D64131C23EQ34152661-BA6E9217-9E89-4A82-B0F9-A3BA950EB1A4Q34261516-760016A0-A252-482D-B048-2F14C4E47073Q34261541-D241E660-49EB-4733-AB1C-1B8EC4FA0949Q34261616-5C907D3D-D531-4546-9E9C-C5C92871257BQ34291012-42A28C58-1D0D-410C-B91E-E73D65C49A4CQ34463574-235E7C7F-3011-48E0-B67E-B244FE8E3063Q34593578-B638604A-02BA-43CC-B571-E8FDDA542E4DQ34780031-7EBFB4CF-F927-4563-BD11-1E98845F700BQ35044801-9850320C-F3CD-47A4-840A-6429CA627B5FQ35344020-B87ECF1B-BDA6-4F75-8B4E-6CBE134F8B92Q35559055-032558B4-6BDB-4401-BB4D-A11E70D81948Q35598040-F771FA9C-51E3-43EA-943F-FA801F702626Q35660049-1C35FCF9-8121-4740-92F8-3A1D4E3EC6A8Q36095703-D3CC9E42-21B0-4B01-BF48-B401AA90F589Q36283285-A59173D3-EB35-429A-AD78-2F86C2EDE6EEQ36835873-536B8F9C-31B4-458E-B4A7-279452EFFD38Q37252823-D81BC8F2-DD34-405F-8F61-B73290AF6BFCQ37481314-B13A1F4C-40B8-4F3B-842A-9ED4D42772FCQ37538046-8907DA2D-2A3C-4919-97E4-5899A5EECB71Q37596746-D6DD7B2A-1BE1-42C7-B3EF-5D6018A7758EQ37683519-6C77EC92-342E-4479-8858-2B657A4D832E
P2860
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A noncovalent class of papain- ...... blocks SARS virus replication.
@ast
A noncovalent class of papain- ...... blocks SARS virus replication.
@en
type
label
A noncovalent class of papain- ...... blocks SARS virus replication.
@ast
A noncovalent class of papain- ...... blocks SARS virus replication.
@en
prefLabel
A noncovalent class of papain- ...... blocks SARS virus replication.
@ast
A noncovalent class of papain- ...... blocks SARS virus replication.
@en
P2093
P2860
P356
P1476
A noncovalent class of papain- ...... blocks SARS virus replication.
@en
P2093
Arun K Ghosh
Bellur S Prabhakar
Jun Takayama
Katrina Sleeman
Kiira Ratia
Melissa Coughlin
Rima Chaudhuri
Scott Pegan
Surendranath Baliji
Susan C Baker
P2860
P304
16119-16124
P356
10.1073/PNAS.0805240105
P407
P577
2008-10-13T00:00:00Z